Isatin: Diverse biological profile

Der Pharmacia Lettre

Volumn 5, Issue 1, 2013, Pages 285-295

  Chaudhary, Dhruv Kumar ^a   Ahmad, Shamim ^a   Maity, Supriya ^a   Alam, M Shamsher ^a  

^a Translam Institute of Pharmaceutical Education and Research   (India)

Author keywords

Anthelmintic; Antibacterial; Anticancer; Anticonvulsant etc; Isatin

Indexed keywords

(6 NITRO 1 THIA 3,4,9 TRIAZA FLUOREN 2 YL)PYRIDIN 2 YLMETHYLENE AMINE; 1H INDOLE 2,3 DIONE DERIVATIVE; 2 PYRAZOLINE; 3 [(5 BENZYLIDENE 2 PHENYL) 3,5 DIHYDRO 4H IMIDAZOL 4 ONE 3 (4 BEZOYL HYDRAZONO)]INDOL 2 ONE DERIVATIVE; 3 [1 ISOPROPENYL 1,3 DIHYDROBENZIMIDAZOL 2 YLIDENE] 1,3 DIHYDRO INDOL 2 ONE; 3 [4 (4 DIMETHYLAMINOBENZYLIDENEAMINO)PHENYLIMINO]INDOLIN 2 ONE; 3 ARYL 5 ARYLIDENE SPIRO[3H INDOLE 3,2 THIAZOLIDINE] 2,4' (1H)DIONE; 3 HYDROXY 3 (2 IMINO 3 METHYL 5 OXOIMIDAZOLIDIN 4 YL)INDOLIN 2 ONE DERIVATIVE; 3,4 DIHYDRO 3 [2 MERCAPTOTHIAZOLIDINE]INDOL 2 ONE DERIVATIVE; 3H SPIRO [1,3 BENZOTHIAZOLE 2,3' INDOL] 2' (1H)ONE; 5 SPIRO (ISATIN) 2 HYDRAZINO DELTA2 1,3,4 OXADIAZOLINE; 5,7 DIBROMOISATIN DERIVATIVE; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ARYL AMINE DERIVATIVE; HYDRAZIDE DERIVATIVE; INDOLE DERIVATIVE; ISATIN; ISATIN 3 GLYCINE COBALT COMPLEX; ISATIN 3 GLYCINE COPPER COMPLEX; ISATIN 3 GLYCINE ZINC COMPLEX; ISATIN DERIVATIVE; N [3 (2 OXO 1,2 DIHYDROINDOL 3 YLIDENE HYDRAZINOCARBONYL)BENZYL]NICOTINAMIDE DERIVATIVE; N ALKYLPHTHALIMIDO ISATIN; N' (1 ALKYL 2,3 DIHYDRO 2 OXO 1H 3 INDOLYLIDEN) 4 PYRIDINECARBOXYLIC ACID HYDRAZIDE DERIVATIVE; PTERIDINE DERIVATIVE; SPIRO [3H INDOLE 3,2' THIAZOLIDINE] 2,4' (1H)DIONE 3' ALKANOIC ACID ESTER; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANALGESIC ACTIVITY; ANTHELMINTIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BACILLUS PUMILUS; BACILLUS SUBTILIS; DRUG DETERMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HUMAN; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIUM CHRYSOGENUM; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; THANATEPHORUS CUCUMERIS; VIBRIO PARAHAEMOLYTICUS;

EID: 84875383182     PISSN: None     EISSN: 09755071     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Nathani BR., Pandya KS., Jeni MM and Patel MR., Der Pharma Chemica., 2011, 3(4), 367-372.
2. Patel A., Bari S., Talele G., Patel J and Sarangapani M., Iranian J. Pharm. Res., 2006, 4, 249-254.
3. Pandeya SN., Srivastava M., Pathak AK and Nath G., J. Pharm. Res., 2010, 3(9), 2270-2272.
4. Prakash CR., Raja1 S., Saravanan G., Kumar DP and Selvam TP., Asian J. Res. Pharm. Sci., 2011, 1(4), 140-143.
5. Saini L., Jain A and Bhadoriya U., Asian J. Pharm. and life sci., 2011, 1, (3),232-238.
6. Madhu., Priyanka B., Maharaj., Krishnaveni J., Brahmeshwari G., Sarangapani M and Sammaiah G., J.A. Pharm. Sci., 2011 ,1(1), 20-33.
7. RavichandranV., Mohan S., Suresh Kumar K., ARKIVOC., 2007,14, 51-57.
8. Patro VJ., Panda CS., Panda V., Panda SS., Sahoo B and Mishra NK., Asian J. Bio chemical and Pharm. Res., 2011, 1(3), 470-475.
9. Bhardwaj S., Kumar L., Verma R and Singh U K., J. Pharm. Res., 2010,3(12), 2983-2985.
10. Fadl TA., Mohammed FAH and Hassan EAS., Arch Pharm. Res., 2000, 26(10), 778-784.
11. Pardasani RT., Pardasani P., Muktawat S.,and Chaturvedi V., Phosp.Silic.Sulp., 1998, 142, 221-227.
12. Kaminskyy D., Khyluk D., Vasylenko O., Zaprutko L and Lesyk R., Sci Pharm., 2011,79,763-777.
13. Shaabanzadeh M., Khabari F., Yavari R and Azim OA., J. Sci. I. A. U (JSIAU), 2010,20,76-82
14. Ge P.,and Kalwan TI,. Bio-org and Med. Chem. Letters., 1997,7(23), 3023-3026.
15. Islam R., and Mohsin M., Bangladesh J. Pharmacol ., 2007, 2,7-12.
16. Krishnegowda G., Gowda ASP., Tagaram HRS., Carroll KFSO., Irby RB., Sharma AK and Amin S., Bio org and Med. Chem., 2011, 19(20), 6006-6014.
17. Matesic L., Locke JM., Vine KL., Ranson M., Bremner JB and Skropeta D., Bio org and Med. Chem., 2011,19,5,1771-1778.
18. Penthala NR., Yerramreddy TR., Madadi NR and Crooks PA., Bio-org and Medi. Chem. Letters., 2010,20,15,4468-4471.
19. Karal N., Guzel O., Ozsoy N., Ozbey S and Salman A., Euro. J. Med. Chem., 2010,45,3,1086-1077.
20. Singh P., Kaur S., KumarV., Bedi PMS., Mahajan MP., Sehar I., Pal HR and Saxena AK., Bio org and Med. Chem. Letters., 2011,21,10,3017-3020.
21. PrakashCR., Raja S and Saravanan G., I.J. Pharm and Pharmaceutical Sci., 2010,2,4,177-181.
22. Subudhi BB., PandaaPK., Bhattaa D and JenabA., Iranian J. Pharm. Sci. Spring., 2009, 5,2, 83-88.
23. Ragavendran JV., Sriram D., Patel SK., Reddy IV. and Bhathwajan N., Euro. J. Med.Chem., 2007,42,146-151.
24. Prasad BD., Vasanthi R., Kanth BC., Prabhakar D and Mohan MR., I. J. Bio and Pharm Res. 2012,3,1,182-187.
25. Panneerselvam P., Reddy RS., Murali K. and Kumar NR., Der Pharm. Chem., 2010, 2,1, 28-37.
26. Ramachandran S and Uma Maheswari V., I.J. Pharm. and Bio Sci., 2011,2,1,251-260.
27. Matheus ME., Violante FDA., Garden SJ. and Pinto AC., Euro. J. Pharmcol., 2007,556, 200-206.
28. Prakash CR., Raja1 S., Saravanan G, Kumar DP and Selvam TP., Asian J. Res. Pharm. Sci.,2011, 1,4,140-143.
29. Naik N., Kumar HV and Vidyashree PB., J. Pharma Res., 2011,4,8,2686-2689.
30. Mondal P., Jana S and Kanthal LK., T. Pharm. Res.)., 2010,3, 17-26.
31. Burnelli S., Andreani A., Granaiola M. and Leoni A., Euro. J. Med. Chem., 2010,45,1374-1378.
32. Reddy RK., J. Chil. Chem. Soc.,2008, 53,4,1653-1657.